Translumina is a leading cardiovascular medical device company dedicated to advancing interventional cardiology through innovative technologies and high-quality products. Its comprehensive portfolio includes drug-eluting stents, drug-coated balloons, vascular accessories, and specialized intervention solutions designed to improve patient outcomes. With a strong focus on research, clinical excellence, and physician support, Translumina continues to deliver cutting-edge cardiovascular therapies that meet global healthcare standards and address evolving clinical needs across international markets.